<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>83(11)</volume><submitter>Lee JH</submitter><pubmed_abstract>The cell envelopes of many Gram-positive bacteria contain wall teichoic acids (WTAs). Staphylococcus aureus WTAs are composed of ribitol phosphate (RboP) or glycerol phosphate (GroP) backbones substituted with D-alanine and N-acetyl-D-glucosamine (GlcNAc) or N-acetyl-D-galactosamine (GalNAc). Two WTA glycosyltransferases, TarM and TarS, are responsible for modifying the RboP WTA with α-GlcNAc and β-GlcNAc, respectively. We recently reported that purified human serum anti-WTA IgG specifically recognizes β-GlcNAc of the staphylococcal RboP WTA and then facilitates complement C3 deposition and opsonophagocytosis of S. aureus laboratory strains. This prompted us to examine whether anti-WTA IgG can induce C3 deposition on a diverse set of clinical S. aureus isolates. To this end, we compared an</pubmed_abstract><journal>Infection and immunity</journal><pagination>4247-55</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4598408</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Surface Glycopolymers Are Crucial for In Vitro Anti-Wall Teichoic Acid IgG-Mediated Complement Activation and Opsonophagocytosis of Staphylococcus aureus.</pubmed_title><pmcid>PMC4598408</pmcid><pubmed_authors>Winstel V</pubmed_authors><pubmed_authors>Lee BL</pubmed_authors><pubmed_authors>Peschel A</pubmed_authors><pubmed_authors>An JH</pubmed_authors><pubmed_authors>Seong MY</pubmed_authors><pubmed_authors>Khan A</pubmed_authors><pubmed_authors>Kurokawa K</pubmed_authors><pubmed_authors>Larsen J</pubmed_authors><pubmed_authors>Andersen PS</pubmed_authors><pubmed_authors>Kim NH</pubmed_authors><pubmed_authors>Lee JH</pubmed_authors><pubmed_authors>Lee MJ</pubmed_authors></additional><is_claimable>false</is_claimable><name>Surface Glycopolymers Are Crucial for In Vitro Anti-Wall Teichoic Acid IgG-Mediated Complement Activation and Opsonophagocytosis of Staphylococcus aureus.</name><description>The cell envelopes of many Gram-positive bacteria contain wall teichoic acids (WTAs). Staphylococcus aureus WTAs are composed of ribitol phosphate (RboP) or glycerol phosphate (GroP) backbones substituted with D-alanine and N-acetyl-D-glucosamine (GlcNAc) or N-acetyl-D-galactosamine (GalNAc). Two WTA glycosyltransferases, TarM and TarS, are responsible for modifying the RboP WTA with α-GlcNAc and β-GlcNAc, respectively. We recently reported that purified human serum anti-WTA IgG specifically recognizes β-GlcNAc of the staphylococcal RboP WTA and then facilitates complement C3 deposition and opsonophagocytosis of S. aureus laboratory strains. This prompted us to examine whether anti-WTA IgG can induce C3 deposition on a diverse set of clinical S. aureus isolates. To this end, we compared an</description><dates><release>2015-01-01T00:00:00Z</release><publication>2015 Nov</publication><modification>2026-05-03T07:44:03.562Z</modification><creation>2019-03-27T01:59:44Z</creation></dates><accession>S-EPMC4598408</accession><cross_references><pubmed>26283333</pubmed><doi>10.1128/IAI.00767-15</doi><doi>10.1128/iai.00767-15</doi></cross_references></HashMap>